search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
127 new news items in the last 24 hours
  1. Home
  2. International

A German team has developed an mRNA vaccine against foot-and-mouth disease, showing promising results in tests on cows without adverse effects.

Raluca Niculae
whatsapp
facebook
linkedin
x
copy-link copy-link
19 August 2025, 19:40
main event image
International
Foto: Shutterstock
google-preference

Always see our news on Google

The Friedrich Loeffler Institute in Germany has announced the successful testing of an experimental mRNA vaccine against foot-and-mouth disease (FMD), which could improve virus management. This vaccine uses fragments of the virus's genetic code, avoiding the need to manipulate live virus, making it safer. In tests, vaccinated cows showed no symptoms and shed less virus than unvaccinated cows. This is a significant achievement, given that foot-and-mouth disease severely affects animals but poses no risk to humans. Further studies are underway to approve the vaccine.

Sources

sursa imagine
Profit.ro
Cercetătorii germani au testat cu succes un vaccin pe bază de ARNm împotriva febrei aftoase
sursa imagine
Stiripesurse
Cercetătorii germani au testat cu succes un vaccin pe bază de ARNm împotriva febrei aftoase
sursa imagine
Stirile ProTV
Cercetătorii germani au testat cu succes un vaccin împotriva febrei aftoase. Acesta folosește tehnologia ARNm
sursa imagine
Agerpres
Cercetătorii germani au testat cu succes un vaccin pe bază de ARNm împotriva febrei aftoase

Latest News

21:57

Alexandru Nazare estimates the beginning of deflation this autumn.

21:39

Volodymyr Zelensky will make a visit to Serbia on Saturday, marking his first trip to this country since the beginning of the Russian invasion.

21:35

The authorities in Turkey announced the discovery of a statue group in Aspendos, representing the god of medicine Asklepios and his son Telesphoros.

21:19

France prohibits unsolicited commercial calls: fines of up to 375,000 euros for companies

21:09

Minister Irineu Darău initiated a dialogue with the management of companies and unions in the defense industry to identify solutions for increasing competitiveness.

See more news

NEWS ON THE SAME TOPICS

event image
Health
Brazil suspends the world's first vaccine against dengue fever after two deaths under investigation
event image
International
The first doses of an experimental antiviral are being urgently sent to France, Spain, and the Netherlands, following an outbreak of hantavirus on a cruise ship.
event image
Health
An experimental injection against cancer completely eliminated tumors in patients who did not respond to chemotherapy or immunotherapy.
event image
EU
The European Commission is investigating Sanofi for the possible disparagement of a rival flu vaccine intended for vulnerable patients.
event image
Health
The Coalition for Innovations in Epidemic Preparedness will invest in the development of three experimental vaccines against the Ebola virus.
event image
Health
India has authorized the use of the Qdenga vaccine against dengue fever
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
vaccination foot and mouth disease Germany test success

Editor’s Recommendations

main event image
Current Affairs
9 hours ago

The authorities officially recommend reducing energy consumption. The government asks the population and companies to reduce consumption between 7:00 PM and 11:00 PM, until August 31.

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
imagine sursa
+4
main event image
Opinions
7 hours ago
Editorials and opinions

The open society and its narrative enemies

main event image
Opinions
11 hours ago

Andrei Pleșu: 1871-2019 – immortal Romanian traditions

main event image
Exclusive
7 hours ago
Original Content

EXCLUSIVE The top themes in domestic politics in trends, in the last week

main event image
Opinions
8 hours ago

Romania closed its coal on paper and built gas plants from words

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol